Mary Alice Carter, senior adviser to Equity Forward, a watchdog group that monitors the influence of abortion opponents within the administration, said the use of old cell lines derived from fetal tissue opposed in the letter is parallel to Regeneron’s use of the material to test experimental antibodies against the virus.
Carter said that Trump “has politically sided with folks who want to see these cell lines no longer used for therapies but went ahead and received it himself.”